ASX Investor Update Podcast

Australian Securities Exchange

Business, Business News, Investing


Four strong biotechs in 2014

May 18th, 2014

Episode 45 of 74 episodes

Stuart Roberts, Baillieu Holst - Australian life science stocks are well regarded but it’s a volatile sector. Biotech analyst Stuart Roberts explains why these four stocks have done well this year.